Description
An antagonist of CCR9 (IC50 = 5.4 nM); selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s = >10 µM for all); inhibits CCL25-induced Molt-4 chemotaxis in 0.1% BSA/HBSS and in 100% human AB serum (IC50s = 3.5 and 33.4 nM, respectively)
Formal name: N-[4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl]-4-(1,1-dimethylethyl)-benzenesulfonamide
Synonyms: CCX282-B|GSK1605786
Molecular weight: 444.9
CAS: 698394-73-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Immunology & Inflammation|Adaptive Immunity